Bispecific anti-CD20 / anti-CD3 antibodies for treating acute lymphoblastic leukemia
MA44145AUndetermined Publication Date: 2018-10-31REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA44145
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-03-09
- Filing Date
- 2016-12-21
- Publication Date
- 2018-10-31
Need to check novelty before this filing date? Find Prior Art
No text content released.